Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Medipense Proposes Cure for Medication Adherence Challenge
  • USA - English


News provided by

Medipense Inc.

Jul 01, 2016, 03:00 ET

Share this article

Share toX

Share this article

Share toX


Montreal, Canada (PRWEB) July 01, 2016 -- Medipense is pleased to propose a cure for medication non-adherence, using its innovative medication management and remote patient monitoring device, the RxPense® Hub featuring Circle-of-Care support. Complete details were recently published in the White Paper: “A Cure for Medication Non-adherence”, available for free download on the Medipense.com web site.

The Challenge

the cost of treating non-adherent chronic disease patients is at least twice as high as adherent patients with the same conditions

Post this

With over 4 billion prescriptions filled annually in America, people get sicker, return to hospitals or die needlessly due to medication errors and medication non-adherence. Between 20% to 80% of patients make errors in taking medication and 20% to 60% stop taking medications before being instructed to do so. In addition, 16 percent of patients fail to fill a new prescription and 30% of prescriptions are never refilled.

In the USA, “86% of health care dollars are spent on the treatment of chronic diseases” according to the CDC.
Dispensing errors are flagrant. There are many points of failure between the time a physician prescribes, and a patient consumes. These failures occur in the hospital, long term care facility, seniors’ residences and at home. At almost every stage where there is human involvement, there are potential sources of error.

…the cost of treating non-adherent chronic disease patients is at least twice as high as adherent patients with the same conditions

From a financial perspective, waste is consuming our health care dollars. The United States spends nearly $300 billion USD a year on additional doctor visits, emergency room visits and hospital admissions due to medication non-adherence. Billions more are wasted around the world. The US pharmaceutical industry alone loses an estimated $188 billion annually due to medication non-adherence. Imagine what that extra revenue could yield in reduced pharmaceutical costs and increased research and development.

The Solution

Solving the medication adherence problem is actually quite simple. In Medipense's white paper, one begins by reviewing the end-to-end medication process, examining each potential point of failure and proposing a multifaceted solution. Finally, there must be follow-up. Automation and patient empowerment play key roles in the enhancement of medication adherence.

One major part of the cure is RxPense®, a personal medication dispensing (automatic pill dispenser) and remote monitoring solution that ensures Seniors, Disabled Veterans, Chronic Care Patients or Clinical Trial Participants, take the correct medications on time and promptly notifies caregivers or Health Care Providers if they miss a dose. It can also capture (though external sensors), monitor and store vitals along with the electronic patient record for better follow-up. It gives users access to digital health care and tele-medicine, re-enforcing patient empowerment, enabling monitoring and improving outcomes.

Benefits for Health System Stakeholders

Increasing medication adherence through automation, empowerment and monitoring improves patient outcomes and achieves benefits for all health system stakeholders:

• Government, insurance and other payers reduce spending - patients who are more adherent with medication regimes use fewer health services
• Healthcare professionals and providers deliver better care more efficiently at lower risk
• Pharmaceutical companies increase profitability and deliver value beyond the pill
• Pharmacy retailers ensure repeat orders, increased fulfillment and enhance brand loyalty
• Physicians have the opportunity to become proactive, rather than reactive

Every one percent improvement in medication adherence results in $2 billion in savings to the U.S. healthcare system and a $4 billion revenue increase to pharmaceuticals.

Benefits for Patients

The benefits for patients includes a better quality of life, fewer hospital visits, better health outcomes, reduced travel and health costs and increased social interaction with family and friends.
 
About Medipense Inc.

Medipense is bringing digital health to an aging population by developing leading edge products and services to specifically address the needs of seniors, those suffering from chronic diseases and the infirm. Whether it’s for home health monitoring, remote health monitoring or on-site secure medication access, with RxPense® it combines the convenience of machine automation with senior-friendly software interfaces to create a unique experience and maximize medication compliance.

# # #

For more information about this topic, please contact Graeme Maag at 438-288-2826 , Ext: 703 or email at info(at)medipense(dot)com.

Graeme Maag, Medipense Inc., http://www.medipense.com, +1 438-288-2826 Ext: 703, [email protected]

Modal title

MEDIPENSE PROPOSES CURE FOR MEDICATION ADHERENCE CHALLENGE
View PDF
MEDIPENSE PROPOSES CURE FOR MEDICATION ADHERENCE CHALLENGE
MEDIPENSE PROPOSES CURE FOR MEDICATION ADHERENCE CHALLENGE

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.